EQ-TIPS was developed to meet growing interest in evaluating the effectiveness & cost-effectiveness of treatments in very young children 👶 In this paper, @prof-nancy-devlin.bsky.social et al. examine issues in valuing the EQ-TIPS and possible adaptations to valuation methods 👉 bit.ly/4oxl4gF

New paper: "Measuring & Valuing Health Using EuroQol Instruments: New Developments 2025 and Beyond" ▶️open access: tinyurl.com/EuroQol2025u... @fengtastic.bsky.social @beaunebeaune.bsky.social @ellystolk.bsky.social #HealthEconomics #PROMS #HRQOL #EQ-5D #EQ-5D-Y #EQ-HWB-9 #EQ-TIPS #Bolt-ons

Thanks @frasermorton.bsky.social for adding the Australian value set for the EQ-5D-Y-3L to your #rstats #EQ5D package! That was quick work! @euroqol.bsky.social @rich-norman.bsky.social Our paper is available here, open access: ➡️https://tinyurl.com/AussieY-3Lvalueset

I'm looking forward to the 2025 #iHEA Congress, & the pre-congress @euroqol.bsky.social session. Authors: If you're presenting a paper at iHEA & thinking of submitting it to #ValueinHealth - drop me a message! I'll do my best to come to your session. Or just come up & say hi! #healtheconomics #VIH

Will Trump's plan to use 'Reference Pricing' cut US drug prices? This #ValueinHealth paper by Grueger, Martin & Sullivan argues reference pricing is ill-advised & will lead to unintended consequences. open access 👉 tinyurl.com/reference-pr... #Trump #HealthEconomics

News from the English NHS: www.bbc.com/news/article... #genomics #precisionmedicine @eigen-uom.bsky.social

New impact factor for Value in Health. We're chuffed! #healtheconomics

This letter, in the June issue of Value in Health, makes for pretty interesting reading: www.valueinhealthjournal.com/article/S109... #healtheconomics #equity #HTA

New Value in Health paper, "Drop the M", of interest to anyone struggling with how to interpret data from patient reported outcome measures, and what a Minimally Important Difference means. Authors: Vickers, Nolla & Cella. 👉 pubmed.ncbi.nlm.nih.gov/40216310/ #HealthEconomics

Hey @altmetric.com, I was wondering if you've got any updates on this you could share? #AcadmicSky #EconSky

Two great philosophers retiring. Two conferences to honour them. Two great line ups. Both open to the public. Sign up. Jo Wolff www.bsg.ox.ac.uk/events/publi... & Jeff McMahan www.ccc.ox.ac.uk/alumni/event...

Tomorrow at #ISPOR2025: in this 75-min 'spotlight' session we will give in-depth consideration of whether Cost Benefit Analysis could play a bigger role in HTA. If you are here in Montreal, I hope to see you there! #HealthEconomics

An update on NICE methods regarding health inequalities in health technology evaluations is out now: tinyurl.com/NICEmethodsh... #HealthEconomics

@euroqol.bsky.social puts out these useful posts regularly, where they do a quick ‘round-up ’ of new papers published about EQ-5D and related instruments. I find therir posts very helpful. If you’re interested in HRQoL, utilities etc, it’s worth following them! #HealthEconomics #PROMs

#ISPORAnnual Virginia Acha notes that tough pricing regulation in the US will reduce incentives for investment in innovation - and this is a double whammy if coupled with reduced US funding of basic science. #referencepricing #HealthEconomics

At ISPOR 2025 Darius Lakdawalla: some form of price intervention is now inevitable in the US, hopefully based on value, and done in a ‘US specific way’. Time for the US to adopt its own HTA.

At today’s ISPOR conference: Sean Sullivan arguing US reference pricing is ‘lazy and misguided’ - but has bipartisan support.

I'm guessing this is going to be a hot topic of conversation here at ISPOR Montreal over the coming days! www.theguardian.com/business/202... #HealthEconomics

Will the US introduce 'reference pricing'? www.reuters.com/business/hea...

[1/2] "24 yrs After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars & Generics for Orphan Medicinal Products"by Sibren van den Berg & colleagues in the May issue of Value in Health @amsterdamumc.bsky.social 👉 tinyurl.com/EUOrphanMeds #HealthEconomics

"The Price Effects of Biosimilars In the US" by Mireia Jofre-Bonet et al. concludes the US biosimilars market has become highly competitive; driving price reductions between 2015-2023 with substantial savings for Medicare ➡️ tinyurl.com/PriceEffects... @ohenews.bsky.social #HealthEconomics

Are women under-represented in publishing in #HealthEconomics? We did an analysis of submissions and acceptances to Value in Health. Results are quite encouraging - but still scope for improvement. open access paper here: tinyurl.com/WomenAuthors...

What is 'Whole Health' and what does it mean for approaches to economic evaluation? The new issue of Value in Health has articles on this from US CDC, WHO & ISPOR, and this little editorial from me & fellow editors Daniel Mullins & Pieter van Baal: 👉 tinyurl.com/WhatDoesWhol... #HealthEconomics

I love it when someone really interesting is interviewed on the news sitting in front of their bookcase. @maryrziegler.bsky.social's new book, 'Personhood: The New Civil War Over Reproduction' now added to my reading list. @cnn.com

When QALYs, VAS and standard gamble make it onto TV... tinyurl.com/38xvf8vy

Indiana state legislature just staged a hostile takeover of IU, functionally eliminating tenure, promising to close smaller (hum) majors, taking over the IU board, and cutting the IU budget. This is so bleak

Since it’s the weekend- what are you all reading? Here are my favourite books from the last six months. ‘Atlas of AI’, ‘Character Limit’ & ‘Careless People’ all strongly recommended to understand the tech world. And some excellent fiction for temporary respite from it! #booksky @rcshuker.bsky.social

How are X and @bsky.app performing as platforms for disseminating research? Fascinating @altmetric.com analysis here: www.altmetric.com/blog/bluesky... #AcademicSky #EconSky

Hey everyone! Well known British professor of health economics @paul-kind.bsky.social has joined @bsky.app. Paul always has interesting/thought provoking things to say- give him a follow! #healtheconomics

Joe's remarkable scholarship and dedication have shaped the field of health economics in broad, deep, and enduring ways. Congratulations. www.aeaweb.org/about-aea/ho...

Having lived in the UK for several decades, I am still not adjusted to the topsy-turvy seasons back in NZ. It's Autumn and it's cold - but it's Easter holidays - so we hid the kids' easter eggs in the piles of fallen leaves & thinking about carving a pumpkin...with... a rabbit face?!

"Using Outcome Information During Consultation Yields Better Shared Decision Making, Better Patient Experiences, and More Positive Expectations" - paper on the use of PROs data in clinical settings, in April 2025 issue of Value in Health by Loos et al. ➡️ tinyurl.com/9fb6m4k7 #HealthEconomics #PROMs

Also at ISPOR Montreal 2025: I'll be moderating this in-depth session on the use of CBA in #HealthEconomics Friday 16th May 10-11.15am

1/2 Going to ISPOR Montreal 2025? May 15th 11.30am: Value in Health's editors-in-chief are having a 'fireside chat' with the lead authors of the 'Paper of the Year' in 2024 (Aurelie Meunier) & 2023 @peterneumann.bsky.social

I worry that some topics addressed in health econ journals could draw fire just because (stupidly) they 'sound a bit like DEI' e.g. DCEA methods, health inequality aversion; analysis of policies to improve access. Editors of academic journals need to be ready to defend independence #HealthEconomics

Congratulations @martingaynor.bsky.social! #HealthEconomics

The first time I saw this, I thought it was a joke. But nope - Reading to Dogs is an actual thing that happens every Monday night at my lovely little local library here in Wānaka, New Zealand. #libraries #literacy#Libsky

What role does equity play in health technology assessment in Asia? New paper in Value in Health reviews current practice in 13 countries. Conclusion: Equity is considered in HTA, but use of quant methods (like DCEA) still relatively rare. tinyurl.com/HealthEquity... #HTA #HeathEconomics #equity

1/2 In the April issue of Value in Health: this fascinating paper, using qualitative analysis to investigate 'How Individuals Value Worse-Than-Dead EQ-5D-5L Health States' using the composite TTO which is a standard part of @euroqol.bsky.social 'EQ-VT' valuation protocols. #HealthEconomics

Out now: the April 2025 issue of Value in Health features 8 papers on the economics of Alzheimers & related dementias; plus papers on a wide range of other topics in health economics & outcomes research. 👉 www.valueinhealthjournal.com/current #Alzheimers #HealthEconomics #ValueinHealth

This looks like a really interesting initiative that could yield useful advancements in methods, evidence & decision making. Well done @nihr.bsky.social @arc-west.bsky.social (& congrats @csrejon.bsky.social!) #HealthEconomics #ImplementationScience

At nearly every conference I have been to....(I won't name names!)

To offer a little moment of calm - here's a picture from southern New Zealand, where I live. It's Autumn here, it's peaceful, and it's beautiful. I wish you all a peaceful and happy weekend, wherever you are.

@altmetric.com are doing fantastic work identifying clinical guidelines from organisations around the world, allowing mentions of research findings in these guidelines to be tracked and reported as impact. updates.altmetric.com/announcement... #clinicalguidelines #healtheconomics #HTA #impact

SO happy for my PhD student Marie-Anne Boujaoude who has won 2025 iHEA 1st prize for her paper reporting health inequality aversion parameters for Australia. You can find her paper here: ➡️https://tinyurl.com/healthinequalityaversion #HealthEconomics #HTA #inequality #DCEA

Two learned society tips for #FollowFriday The Society for #PsychotherapyResearch has joined @sprofficial.bsky.social as has the EuroQol Research Foundation bsky.app/profile/euro... Both have not posted much (yet), but had (have? 🤷😅) a good presence elsewhere. #HealthEconomics #PatientCentered

A look ahead to the April 2025 issue of Value in Health: this article is available early/online now: ➡️https://www.valueinhealthjournal.com/article/S1098-3015(25)00116-0/fulltext #healtheconomics #HTA #HEOR

When Cost Effectiveness Planes Go Wrong. #HTA #CEA

www.sciencedirect.com/science/arti... New paper alert from the brilliant Dr Raymond Henderson and his Co-authors from the ISPOR Open Source Models Special Interest Group #healtheconomics #Rprogramming #HEOR #opensource #ISPOR

1/2 Hey everyone, give @euroqol.bsky.social a big warm welcome to @bsky.app & give 'em a follow! Euroqol is the not-for-profit organisation which developed the EQ-5D & is a major funder of research on measuring/valuing health related quality of life around the world. euroqol.org/about-us/new...